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ABSTRACT
Introduction  Compliance with hypertension guidelines in clinical practice is generally poor, but there was no data about compli-
ance with any guidelines in general practice in Slovenia.
Objective  Our aim was to find out whether general practitioners in Slovenia managed their hypertensive patients according to the 
national guidelines, based on 1999 WHO/ISH guideline recommendations.
Method  42 family physicians registered all patients with the diagnosis of arterial hypertension among 300 consecutive regular of-
fice visits. We used data about blood pressure management from paper medical records.
Results  We collected data from 2752 patients with hypertension; the mean age was 64.1 years (SD = 12.4 years, from 21 to 97 years). 
All elements of the minimal diagnostic program in the last five years were performed in 23.8% of the patients. In 1809 (65.7%) patients, 
whose cardiovascular risk was estimated, the minimal diagnostic program was performed more frequently (p<0.001). Non-pharma-
cological measures were performed in 1210 (47.0%) patients. 2649 (97.6%) patients had drug therapy in accordance with the guide-
lines. Follow-up in accordance with the guidelines was performed in 1492 (55.3%) patients. Only 256 (9.3%) patients were managed 
completely according to the guidelines and only 347 (15.5%) of study population reached the target values of blood pressure.
Conclusion  The impact of hypertension guidelines on patients’ management in everyday primary care appears marginal. More em-
phasis should be placed on the efficient implementation of the guidelines.
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INTRODUCTION
Arterial hypertension is one of the most frequent 
health problems in clinical practice. Almost half of the 
European population suffers from hypertension [1]. Pro-
spective studies have clearly identified an increasing risk 
for cardiovascular disease, stroke and renal disease asso-
ciated with progressive levels of both systolic and dia-
stolic blood pressure [2, 3], but results of several ran-
domized controlled trials [4, 5] and results of clinical tri-
als made in general practice [6, 7] have shown that anti-
hypertensive treatment reduces morbidity and mortali-
ty in hypertensive patients. In spite of the availability of 
International and National Guidelines on Management 
of Hypertension, a considerable gap exists between evi-
dence-based guidelines and management of patients with 
arterial hypertension in practice [8-10]. The number of 
inadequately treated patients is high [11]. In a small Slo-
venian study, only 9% of all hypertensive patients man-
aged in family practice achieved target blood pressure val-
ues equal to or less than 130/85 mm Hg [12].
Appropriate knowledge of guidelines and attitudes of 
physicians are prerequisites for better adherence to the 
guidelines [13]. For example, an important reason why 
physicians do not treat hypertension more aggressively is 
that they are willing to accept an elevated systolic blood 
pressure in their patients as an acceptable outcome [14]. 
Physicians may still encounter barriers that limit their 
ability to carry out the recommendations more efficient-
ly [13]. These may stem from the guidelines, the environ-
ment or the patients themselves; the key external barri-
ers to better implementation of the guidelines are lack of 
time, prescription costs, and patients’ non-compliance. 
Another important reason for poor hypertension control 
might arise from the physician-patient relationship and 
from inadequate patient involvement in management of 
his/her own chronic disease.
Many physicians use higher values than 140/90 mm 
Hg for the blood pressure threshold for the diagnosis of 
hypertension. It is the threshold recommended by the evi-
dence-based guidelines [8]. Only 10 % of the patients with 
newly diagnosed arterial hypertension had complete clin-
ical and laboratory evaluation according to the minimum 
work-up suggested by the guidelines [16] and many phy-
sicians did not intensify antihypertensive treatment in 
case of persistently high blood pressure readings [8, 17]. 
There are also patients with diagnosis of arterial hyper-
tension who had no blood pressure measurements in the 
office within the previous year [18].
OBJECTIVE
Compliance with guidelines in clinical practice is gen-
erally poor. In Slovenia, we have only a small study about 
compliance with guidelines on heart failure in a commu-
nity hospital [19], but we have no study about compliance 
with any national guidelines in primary care. We want-
ed to study the adherence to the national hypertension 
guidelines in general practitioners in Slovenia, because 
arterial hypertension is one of the most frequent health 
problems in general practice and we have national guide-
lines on hypertension, which were widely distributed to 
all general practitioners.192
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METHOD
Participants
We took a random sample of 50 family physicians from 
the list of the Slovene Family Medicine Society. They were 
chosen randomly from the register of the Slovenian Fam-
ily Physicians’ Society. 42 physicians were willing to par-
ticipate in the study (the response rate was 84%). Each of 
the physicians had to register data on all the patients with 
the diagnosis of arterial hypertension (as defined in the 
patient’s medical records) among 300 consecutive regu-
lar office visits.
We used an entry form containing questions on ret-
rospective data about blood pressure readings, diagnos-
tic and therapeutic procedures in hypertension and fol-
low-up. We also collected data on blood pressure values; 
we used the average of the last two values of blood pres-
sure readings from the medical records; to avoid possi-
ble bias, we excluded the value measured during the vis-
it in which the physician collected the data on the par-
ticipating patient.
As a reference standard, we used the Slovene national 
guidelines on hypertension, published in 2000 [20], based 
on 1999 WHO/ISH and JNC 6 guideline recommenda-
tions, which were in use in Slovenia during the period in 
which we studied the compliance with the guidelines. We 
also collected data about general characteristics of physi-
cians, patients and organization of work.
We collected data on diagnostic procedures in hyper-
tensive patients in accordance with the guidelines: fami-
ly history, history of smoking, body mass index, periph-
eral pulses, eye ground examination, blood sugar, lipids, 
serum creatinine, urine examination, ECG and cardio-
vascular risk estimation. We expected that each diagnos-
tic procedure from the guidelines had to be done at least 
once in the past five years.
According to the guidelines, we also expected that each 
patient with hypertension was given  advice on nonphar-
macological measures in hypertension: advice on salt 
reduction, reduction on alcohol consumption (if appro-
priate), stopping smoking (if appropriate), body mass 
reduction (if appropriate) and regular physical activity. 
For the compliance with nonpharmacological measures 
in hypertension, advice on all non-pharmacological mea-
sures must be written in a medical record at least once in 
the course of known diagnosis of hypertension.
According to the guidelines, six classes of antihyper-
tensive drugs (beta blockers, ACE inhibitors, A2 antag-
onists, calcium channel blockers, diuretics, alpha block-
ers) should be chosen as the first line of treatment, but in 
the case of combination of three or more different kinds 
of antihypertensive drugs, one of them must be a diuretic. 
Compliance with guidelines meant that one of the six drug 
classes was used in monotherapy, in case of two drugs all 
combinations were possible and in a combined antihyper-
tensive drug therapy with three or more different antihy-
pertensive drugs one drug had to be a diuretic.
In the guidelines, there are also recommendations 
about the follow-up of hypertensive patients. The mini-
mal number of visits to the surgery should be for patients 
with the reached blood pressure and with a small to medi-
um cardiovascular risk twice a year and for other patients 
(without reached target blood pressure values or with 
high cardiovascular risk) at least four times per year. We 
accepted these minimal standards for follow-up from the 
guidelines.
Complete clinical and laboratory evaluation accord-
ing to the minimal diagnostic program (suggested by the 
guidelines), nonpharmacological measures in hyperten-
sion (salt and alcohol reduction, regular physical activi-
ty, weight reduction), pharmacological approach and fol-
low-up in accordance with the guidelines was regarded 
as appropriate compliance with national guidelines for 
hypertension.
According to the national guidelines from 1999, the 
target blood pressure for patients younger than 65 years 
and patients with diabetes was less than 130/85 mm Hg 
and for patients whose age was 65 or older the target 
blood pressure was less than 140/90 mm Hg.
Statistical methods
SPSS statistical software (version 12.0) was used for 
all statistical analyses: methods of descriptive statistics 
for the description of samples and t-test for compari-
son between independent samples. The level of signifi-
cance was p<0.05. The study protocol was approved by 
the National Ethical Committee.
RESULTS
42 general practitioners collected data on 12596 regular 
consecutive office visits. Within these visits, 2752 (21.9%) 
visits were made by hypertensive patients. In the group of 
hypertensive patients there were more female than male 
patients (60.7% vs. 39.3%), the mean age was 64.1 years 
(SD = 12.4 years, from 21 to 97 years). 532 (19.3%) patients 
had diabetes mellitus and 881 (32%) patients had an estab-
lished cardiovascular disease. 2713 (98.7%) of the study 
population were on drug therapy for hypertension. Com-
plete diagnostic work-up in hypertension with cardiovas-
cular risk estimation in the past five years was performed 
in 627 patients (22.8%), but clinical examination and all 
recommended laboratory tests and ECG without cardio-
vascular risk estimation were done in 654 (23.8%) patients. 
Table 1 presents numbers and percentages of patients with 
each individual diagnostic procedure done.
Cardiovascular risk was calculated in 1809 patients 
(65.7%). It was calculated significantly more frequently 
in the group of patients with all other diagnostic proce-
dures done, recommended in hypertensive patients (96% 
vs. 56%, p<0.001).
All recommended non-pharmacological measures were 
advised in 1210 patients (47.0%). Table 2 shows numbers 
and percentages of patients who got advice on each non-
pharmacological measure. All the patients treated with 
antihypertensive drug in monotherapy (N=982, 35.9% of 
all patients) took a drug from one of the recommended 
drug classes. Out of 794 (28.6%) patients taking three or 
more different antihypertensive drugs, 691 (87.0%) had a 
diuretic among them. Drug treatment in accordance with 
the guidelines was given to 2649 (97.6%) out of all 2713 
patients on drug treatment for hypertension.  193
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The mean office visit rate in patients with blood pres-
sure reading was 4.3 (from 0 to more than 8, SD 3.3). In 
Table 3, there are numbers and percentages of patients 
regarding the number of office visits per one year.
The mean office visit rate in patients with blood pres-
sure reading was 4.3 (from 0 to more than 8, SD 3.3). In 
Table 3, there are numbers and percentages of patients 
regarding the number of office visits in one year. There 
TABLE 3. Numbers and percentages of patients regarding the number 
of office visits with blood pressure readings in one year (N=2696).
TABELA 3.­Broj­bolesnika­prema­broju­poseta­ambulanti­sa­me­
rewem­krvnog­pritiska­u­jednoj­godini­(N=2696).
Number of visits
Broj poseta
Number
Broj %
0 160  5.9
1 213  7.9
2 383  14. 2
3 448  16.6
4 455  16.9
5 314  11.6
6 290  10.8
7 132  4.9
8 or more / 8­ili­više 301  11.2
TABLE 1. Numbers and percentages of patients with individual ele-
ments of diagnostic procedure performed (N=2752).
TABELA 1.­Broj­bolesnika­sa­izvedenim­pojedinim­elementima­
dijagnostičkog­postupka­(N=2752).
Element of diagnostic procedure
Element dijagnostičkog postupka
Number
Broj %
Family history
Porodična­istorija 1656­ 60.2
Smoking history
Pušačka­istorija 2283­ 83.0
Body mass index
Indeks­telesne­mase 2090­ 75.9
Peripheral pulses
Periferni­pulsevi 1609­ 58.5
Eye-ground examination
Pregled­očne­pozadine 1559­ 56.6
Blood sugar
Šećer­u­krvi 2592­ 94.2
Lipid profile
Lipidni­profil 2492­ 90.6
Serum creatinine
Kreatinin­u­serumu 2257­ 82.0
Urine examination
Pregled­urina 1902­ 69.1
ECG
EKG 2453­ 89.1
TABLE 4. Numbers and percentages of patients with total procedure 
and individual elements of procedure in hypertension in accordance 
with the guidelines.
TABELA 4.­Broj­bolesnika­sa­celokupnim­postupkom­i­pojedinim­ele­
mentima­postupka­u­saglasnosti­sa­smernicama­za­hipertenziju.
Parameter
Parametar
Number
Broj %
Total procedure in accordance  
with the guidelines (N=2738)
Celokupni­postupak­u­saglasnosti­­
sa­smernicama
256  9.3
Diagnostic procedure in accordance  
with the guidelines (N=2752)
Dijagnostički­postupak­u­saglasnosti­
sa­smernicama
627  22.8
Therapeutic procedure in accordance 
with the guidelines (N=2581)
Terapijski­postupak­u­saglasnosti­sa­
smernicama
1163  45.1
Follow-up in accordance with the 
guidelines (N=2696)
Kontrole­u­saglasnosti­­
sa­smernicama
1492  55.3
TABLE 2. Numbers and percentages of patients who got advice for 
non-pharmacological measures in arterial hypertension.
TABELA 2.­Broj­bolesnika­koji­su­dobijali­savete­za­nefarmako­
loške­mere­u­arterijskoj­hipertenziji.
Nonpharmacological measure
Nefarmakološka mera
Number
Broj %
Weight reduction (N=2006)
Smawewe­težine 1380­ 68.8
Alcohol intake reduction (N=806)
Smawewe­unosa­alkohola 385­ 47.8
Stopping smoking (N=582)
Prestanak­pušewa 273­ 46.9
Salt intake reduction (N=2643)
Smawewe­unosa­soli 1649­ 62.7
Regular physical activity (N=2615)
Redovna­fizička­aktivnost 1724­ 65.5
TABLE 5. Numbers and percentages of patients with systolic, diastolic 
and both blood pressure readings at recommended levels.
TABELA 5.­Broj­bolesnika­prema­arterijskom­pritisku­u­prepo­
ručenim­granicama.
Parameter
Parametar
Number
Broj %
Systolic blood pressure at  
recommended levels (N=2471)
Sistolni­krvni­pritisak­u­
preporučenim­­granicama
487  19.7
Diastolic blood pressure at 
recommended levels (N=2478)
Dijastolni­krvni­pritisak­u­
preporučenim­granicama
1295  52.3
Systolic and diastolic blood pressure  
at recommended levels (N= 2530)
Sistolni­i­dijastolni­krvni­pritisak­
u­preporučenim­granicama
347  15.5
were only 65 (2.4%) patients who, according to the guide-
lines, needed at least two office visits in one year; all oth-
er hypertensive patients needed at least four office visits 
per year. Only 1492 (55.3%) of hypertensive patients had 
recommended frequency of office visits with blood pres-
sure readings.
Only 256 (9.3%) patients had diagnostic procedure, 
therapeutic measures (non-pharmacological and phar-
macological) and follow-up according to the guidelines. 
Table 4 shows numbers and percentages of patients for 
total procedure and each procedure separately, which are 
in accordance with the guidelines in hypertension.
The target blood pressure was reached in 347 (15.5%) 
out of 2530 patients for whom we had all the data neces-
sary to estimate the target blood pressure. Table 5 shows 
numbers and percentages of patients with systolic, dia-
stolic and both blood pressure readings at recommend-
ed levels.
DISCUSSION
As in previous studies, we found a wide gap between 
guidelines recommendations and daily clinical prac-
tice [8, 16-19]. Compliance with National guidelines on 194
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hypertension in Slovenian general practitioners is poor; 
less than a quarter of hypertensive patients had diagnos-
tic procedures performed in accordance with the guide-
lines, less than a half of hypertensive patients got appro-
priate advice on non-pharmacological measures, the com-
bined drug therapy was sometimes not optimal, the min-
imal standards for follow-up were fulfilled by only a half 
of all the patients, and only a small proportion of treat-
ed hypertensive patients reached the target blood pres-
sure levels.
We managed to collect data on a relatively large sam-
ple of family practice visitors and identified hypertensive 
patients among them. This allows us a good insight into 
the quality of family practice daily routines. This is also 
the first large study on quality of blood pressure manage-
ment in family practice in our country, which allows us 
generalization related to the whole family practice popu-
lation in Slovenia. The use of similar methodology as in 
many other studies allows for comparisons to internation-
al data [18, 21, 22].
Epidemiology and significance of  
hypertension in Slovenia
According to the prevalence of hypertension in Europe, 
where 44 % of adult population and 67 % of elderly peo-
ple have hypertension [1] and according to the estimat-
ed prevalence of hypertension in Slovenia, which is 42 % 
[23], we found that only a half of the hypertensive patients 
visited their general practitioners.
Under-diagnosed or untreated arterial hypertension 
could be one of the causes for high cardiovascular mortal-
ity in Slovenia as well as in other countries [24]. Mortality 
due to cardiovascular diseases in Slovenia declined from 
48 % in 1988 [25] to 38 % in 2003 [26], but it is still high 
and is the leading cause of mortality. Better recognition 
and treatment of hypertension and other risk factors for 
cardiovascular disease is necessary and a step to this aim 
could be the preventive program for reducing cardiovas-
cular morbidity and mortality, organized at the primary 
level of health care (started in 2002 [27]), and treatment 
of risk factors and cardiovascular diseases according to 
the guidelines recommendations.
Discussion on our own results
Although the minimal diagnostic program in accor-
dance with the guidelines was performed in less than a 
quarter of patients, our results are better than in a sim-
ilar Italian study [16], in which in only 10 % of patients 
the minimal diagnostic program was performed. Some 
of the elements of the minimal diagnostic program, e.g. 
blood laboratory examinations and ECG, were performed 
in the majority of patients, but others, like history, clinical 
examinations with fundoscopy and urine examinations, 
were performed in only two thirds of the patients. Eye 
fundus examination was the least frequently performed 
element of the minimal diagnostic procedure, as in the 
study from Italy, where eye fundus examination was per-
formed in only 19 % of the patients; ECG and blood tests 
were done in only half of the patients [16].
Majority of the primary care physicians in our coun-
try do not perform ophthalmoscopy by themselves and 
patients have to go to the ophthalmologist to perform 
the examination. Another, probably more important 
reason why physicians do not perform diagnostic pro-
cedures according to the guidelines is that they are not 
aware that total cardiovascular risk, which depends on 
the level of blood pressure, is the most important factor 
and the basis for further treatment [20]. Total cardiovas-
cular risk depends on the level of blood pressure, other 
cardiovascular risk factors and target organ damage, and 
for their estimation we need at least the minimal diagnos-
tic procedures in hypertension. Many physicians, who are 
not aware of this, treat their hypertensive patients on the 
basis of the blood pressure level only [10].
Diagnostic and therapeutic procedure and follow-up in 
accordance with the guidelines was found in less than 10% 
of all hypertensive general practice attenders in Slovenia. 
Treatment of hypertension, acknowledging only the level 
of blood pressure, without taking into account concomi-
tant diseases, other risk factors, target organ damage and 
individual differences between patients, might be one of 
the reasons for poor results. Possible other reasons for 
low compliance with hypertensive guidelines could be an 
unacceptable level of knowledge on hypertension guide-
lines among family physicians [28], non-acceptance of 
guidelines recommendations and guidelines recommen-
dations, which might not be appropriate for the use in 
everyday practice [9, 13, 14].
Comparison of our own results  
with the international literature and  
the situation in other countries
Physicians advised all recommended non-pharmaco-
logical measures to less than a half of all the hypertensive 
patients. The results are similar in Germany [29] and bet-
ter than results from Hungary, which showed that only 
one quarter of hypertensive patients got all recommended 
non-pharmacological measures in hypertension [30].
A possible reason for a relatively small proportion of 
patients getting all the recommended non-pharmaco-
logical advice is that physicians, when giving advice on 
non-pharmacological measures in hypertension, do not 
write the advice in patients’ medical records [31]. The 
same phenomenon was found in an epidemiological study 
of arterial hypertension in Slovenia in 1985, where the 
patients reported that they had got advice on non-phar-
macological measures in much higher percentage than 
written in the medical records [32].
Most of the patients with diagnosis of arterial hyper-
tension (98.7%) who attended general practice were 
treated with antihypertensive drugs and less than 2% 
of patients were treated only with non-pharmacological 
measures. The percentage of patients receiving pharma-
cological treatment for hypertension was 83.8% in Ger-
many [29], 85% in Finland and Hungary [30, 33] and 90% 
in Greece [34].
Almost two thirds of the patients had combined anti-
hypertensive therapy, most frequently a fixed combina-
tion of two different drugs. The proportion of patients on 
combined therapy is similar to other European countries   195
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[29, 30, 33]. In case of three or more different classes of 
antihypertensive drugs, a diuretic was included in such a 
combination. Physicians often used fixed combinations 
including a diuretic. There are many fixed combinations 
including a diuretic registered in Slovenia and the use of 
fixed combinations simplify the treatment and improve 
patients’ compliance with treatment [35] and also physi-
cians’ compliance with the guidelines.
The average rate of office visits with blood pressure 
readings was 4.3, but only a half of the patients had the 
minimal acceptable number of blood pressure readings 
(for the majority of the patients at least four in one year) 
in the surgery in one year. There were also hypertensive 
patients without blood pressure readings in the past year, 
but the proportion of them was smaller than in Italy (6% 
versus 17%), and also patients with probably unnecessary 
frequent readings of blood pressure in the surgery (11.2% 
of patients had more than eight blood pressure readings 
in the past year). In the group of patients having at least 
one blood pressure reading in the surgery in the past year, 
there were 77% of patients with at least three readings of 
blood pressure in the past year; the result is similar to the 
result of another study in which 70% of patients with at 
least one blood pressure control in a year had at least three 
blood pressure measurements in the same year [18].
A small proportion of patients (15.5%) had blood pres-
sure level readings in accordance with the guidelines. The 
comparisons of our results with results of other studies on 
blood pressure control in primary care is difficult because 
of the differences in the methodology and the target blood 
pressure level estimated. Data from other studies, done 
in primary care in Europe show that between 8.6% (in 
Poland) [21] and 10% in Finland [36] to 55.6% (in Greece) 
[34] of primary care hypertensive attenders had their 
blood pressure lower than 140/90 mm Hg.
Limitations of the study
This study has some limitations. First of all, the find-
ings are representative for the attenders of general practi-
tice in Slovenia, but not for the entire hypertensive popu-
lation in our country. Another limitation is that we used 
paper medical records as a source of data. Paper medical 
records as a source of data have some advantages (it is eth-
ically acceptable, cheap, retrospective methodology), but 
also some disadvantages. The most important disadvan-
tage is that the quality of data documentation varies from 
physician to physician and that the quality of paper data 
is not always a faithful account of the quality of process of 
care (i.e. adherence to hypertension guidelines) [37].
CONCLUSION
The impact of hypertension guidelines on patients’ 
management in everyday primary care appears to have 
marginal efficacy. Family physicians in Slovenia are either 
not aware of or do not practice calculation of total car-
diovascular risk, which is the most important factor and 
the basis for decisions on future treatment of hyperten-
sion. Most of the Slovene hypertensive patients were treat-
ed with antihypertensive drugs, frequently in combina-
tions. The choice of medication is appropriate. Follow-
up is insufficient and only a small proportion of patients 
reached the recommended target blood pressure values.
More emphasis should be placed on the uptake of 
guidelines using multifaceted strategies for guidelines 
implementation. Patients will have to be empowered to 
take more decisive role in blood pressure control.
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KRATAK SADRŽAJ
Uvod­­Usklađenost­sa­uputstvima­za­hipertenziju­je­u­klini­ čkoj­
praksi­u­načelu­loša,­ali­zasad­nema­podataka­o­saglasnosti­sa­
bilo­kakvim­uputstvima­u­opštoj­praksi­u­Sloveniji.
Ciq rada­­Ciq­rada­je­bio­da­se­otkrije­da­li­lekari­opšte­
medicine­u­Sloveniji­pregledaju­bolesnike­s­hipertenzijom­
u­skladu­s­nacionalnim­uputstvima,­zasnovanim­na­uputstvima­
Svetske­zdravstvene­organizacije­iz­1999.­godine.
Metod rada­­Četrdeset­dva­lekara­opšte­medicine­zabeležila­
su­sve­bolesnike­sa­dijagnozom­arterijske­hipertenzije­između­
300­uzastopnih­poseta­u­ambulanti.­Upotrebqeni­su­i­podaci­o­
merewu­krvnog­pritiska­iz­medicinske­dokumentacije.
Rezultati­­Sakupqeni­su­podaci­od­2.752­bolesnika­s­hiper­
tenzijom,­koji­su­u­proseku­bili­stari­64,1­godinu­(SD­12,4­go­
dine;­21­97­godina).­Svi­elementi­minimalnog­dijagnostičkog­
programa­u­posledwih­pet­godina­primeweni­su­kod­23,8%­bo­
lesnika.­Kod­1.809­bolesnika­(65,7%)­kod­kojih­je­proceweno­
da­postoji­kardiovaskularni­rizik­minimalni­dijagnosti­ čki­
program­je­primewen­češće­(p<0,001).­Nefarmakološke­mere­
bile­su­primewene­kod­1.210­bolesnika­(47,0%),­dok­je­2.649­bo­
lesnika­(97,6%)­lečeno­lekovima­u­saglasnosti­sa­uputstvima.­
Kontrole­u­saglasnosti­sa­uputstvima­bile­su­izvedene­kod­
1.492­bolesnika­(55,3%).­Samo­256­bolesnika­(9,3%)­bilo­je­pre­
gledano­potpuno­u­saglasnosti­sa­uputstvima,­a­samo­347­ispi­
tanika­(15,5%)­dostiglo­je­ciqne­vrednosti­krvnog­pritiska.
Zakqučak­­Uticaj­uputstava­za­hipertenziju­na­pregled­bole­
snika­u­svakodnevnoj­primarnoj­zaštiti­čini­se­neznatnim.­
Ve­ ću­važnost­trebalo­bi­pridati­efikasnoj­primeni­uput­
stava.
Kqučne reči:­kvalitet­zdravstvene­zaštite;­opšta­praksa;­
hipertenzija;­uputstva
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